Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway

por Imran, Aqeel, Shehzad, Muhammad Tariq, Shah, Syed Jawad Ali, Laws, Mark, al-Adhami, Taha, Rahman, Khondaker Miraz, Khan, Imtiaz Ali, Shafiq, Zahid, Iqbal, Jamshed
Publicado 2022

Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study

por Imran, Aqeel, Shehzad, Muhammad Tariq, Shah, Syed Jawad Ali, al Adhami, Taha, Laws, Mark, Rahman, Khondaker Miraz, Alharthy, Rima D., Khan, Imtiaz Ali, Shafiq, Zahid, Iqbal, Jamshed
Publicado 2022

Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors

por Shehzad, Muhammad Tariq, Imran, Aqeel, Hameed, Abdul, Rashida, Mariya al, Bibi, Marium, Uroos, Maliha, Asari, Asnuzilawati, Iftikhar, Shafia, Mohamad, Habsah, Tahir, Muhammad Nawaz, Shafiq, Zahid, Iqbal, Jamshed
Publicado 2021